Tag:
ISIS 301012
Latest Headlines
Latest Headlines
More good news from RNAi company Isis
Isis has been on a good-news roll lately, and today is no exception. The company announced positive results from a Phase II open-label extension trial of of
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- T cells 'hunt' parasites like animal predators seek prey, study shows
- UC San Diego Researchers Receive New CIRM Funding
- Same gene that stunts infants' growth also makes them grow too big
- Chronic Pain Is Relieved by Cell Transplantation in Lab Study
- Drug-vaccine combo better for breast cancer
- More Press Releases
Featured Jobs
-
Quality Assurance Specialist Job
Yoh - Lexington, MA, USA -
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA -
Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA -
Analytical Scientist Job
Yoh - Durham, NC, USA -
Supervisor, QC Chemistry - 3rd Shift Job
Celgene Corporation - Phoenix, AZ, US
